Morphotek
develops biological-based products to treat cancer, inflammation and infectious diseases... Read moreMorphotek
develops biological-based products to treat cancer, inflammation and infectious diseases... Read more
CEO
Add
News
Oct 09, 2018
BioPortfolio
Morphotek: Morphotek Inc Mergers Acquisitions MA Partnerships Alliances and Investment Report Report Updated 28072018 Prices from USD $350
Oct 02, 2018
BioPortfolio
Morphotek: Morphotek Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 07092018 Prices from USD $250
Aug 03, 2018
BioPortfolio
Morphotek: Morphotek Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 23042018 Prices from USD $250
Apr 09, 2018
Reuters
Morphotek: BRIEF-Morphotek Announces Agreement To License Its Eribulin-Linker Payload To Bliss Biopharmaceutical Of China
Apr 08, 2018
BioPortfolio
Morphotek: Morphotek Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13032018 Prices from USD $250
Jan 24, 2018
PR Newswire
Press Release: Morphotek : Morphotek To Present Poster On CA125 Suppression Of Humoral Immune Responses Of Antibodies At The Upcoming ASCO-SITC Clinical Immuno-oncology Symposium
Jan 10, 2018
Reuters
Morphotek: BRIEF-Morphotek Announces FDA Acceptance Of IND For Cancer Treatment
Dec 11, 2017
PR Newswire
Press Release: Morphotek : Morphotek And Rockefeller University Form A Sponsored Research Agreement To Study The Immunosuppressive Effects Of The Tumor Shed Antigen CA125 And Its Potential Impact In Future Patient Therapies
Dec 08, 2017
PIPELINEREVIEW
Morphotek: Morphotek Announces Initiation Of Phase 1 Study Of Next-Generation Farletuzumab Antibody-Drug Conjugate MORAb-202 In Solid Tumors With Folate Receptor Alpha Expression
Dec 07, 2017
streetinsider
Morphotek: Morphotek To Present Its Proprietary RESPECT Antibody-Drug Conjugate (ADC) Technology At The Upcoming Antibody Engineering & Therapeutics Conference In San Diego
Morphotek Competitors
1
2
3
4
5
6
7
8
9
10